Rose Medical Center's comprehensive Breast Center is proud to be one of the first hospitals in the nation to offer the Novilase ILT, a non-surgical treatment for benign (non-cancerous) breast tumors. Novilase ILT provides a minimally invasive alternative to a surgical lumpectomy to remove tumors.
Starting in 2012, Rose will be participating in a clinical trial, using the Novilase ILT treatment for malignant breast tumors. This technology could dramatically change the tradiation course of treatment for breast cancer patients.
To find out if you may be a candidate for the breast cancer Novliase ILT clinical trial, please call 303-320-7138.
To learn more, please view our brochure about the Novilase ILT clinical trial.
Benign Breast Tumors
If your screening mammography and/or breast ultrasound reveals that you have a fibroadenoma(s), the most common type of solid, non-cancerous breast tumor, you and your doctors will discuss having the mass removed. Some patients choose not to have these tumors removed because it requires surgery with sedation; while the tumor itself is not harmful, it does require regular monitoring. Novilase provides an alternative to surgery, cutting down on continual monitoring, as well as providing piece of mind.
How it Works
Novilase ILT is an image-guided laser ablation device that can be used in an outpatient setting. The procedure is typically completed in about an hour, only requires two small nicks, which are closed with band-aids, and uses a laser to heat the tumor until it dissolves. The Novilase procedure is shorter and less invasive in comparison to a lumpectomy, which requires sedation, lasts more than an hour, and includes a 2-3 inch incision that is closed with sutures.
As part of Novilase Interstitial Laser Therapy for the treatment of breast cancer, laser and thermal probes are inserted into the target tumor using imaging guidance. Real-time monitoring of temperature, shown in the graph at top left, is used to determine when the Novilase procedure is complete.